News Story: Full Text
Sponsored By
NovoCure Trial
Please Click On The Above Banner For More Details
Braintumor Website


Brain Tumor Society presents Information is Power … Power is Hope: Connecting Patients, Survivors, Caregivers October 29-30, 2004

Posted on: 07/04/2004

Brain Tumor Society presents Information is Power … Power is Hope: Connecting Patients, Survivors, Caregivers October 29-30, 2004

Contact: Dawn Grenier
Publication Coordinator
800.770.TBTS (8287) ext 16

With keynote speakers Dr. Henry Friedman and Dr. Robert Martuza

Nearly 800 participants are anticipated at the Brain Tumor Society’s 6th Educational Symposium, taking place in Newton, Massachusetts on October 29-30. Information is Power … Power is Hope: Connecting Patients, Survivors, Caregivers and Professionals is part of the Brain Tumor Society’s mission of education and support, along with the Society’s commitment to funding research. This national Symposium offers current medical information, addresses psychosocial issues, and provides networking opportunities for the brain tumor community.

The keynote speakers are nationally recognized practitioners in brain tumor treatment. Dr. Henry Friedman will discuss “Malignant Glioma – Lab to Bedside.” Dr. Friedman is a neuro-oncologist at The Brain Tumor Center at Duke University. He is widely known for his work with clinical trials. Dr. Robert Martuza is the Chief of Neurological Services at Massachusetts General Hospital and a professor of neurosurgery at Harvard Medical School. He will address “Gene Therapy and Brain Tumors.”

Other speakers and panelists include specialists from Dana Farber Cancer Institute, Children’s National Medical Center and Brigham and Women’s Hospital. The Symposium features both adult and pediatric tracks and pays special attention to the psychosocial needs of the brain tumor community in addition to presenting treatment updates.

“When you hear the words ‘you have a brain tumor,’ all you want is information: what should I do next, what’s the best treatment, where’s the best surgeon? The consistent feedback that we hear from patients and families is that our Symposia provide them with this vital information, while also providing the opportunity to connect with others coping with this devastating diagnosis,” said Sarah Duggan, LICSW, Director of Education and Support for the Brain Tumor Society.

This year’s symposium will take place at the Boston Newton Marriott in Newton, Massachusetts. Principal sponsor Schering-Plough supports it, along with Pfizer Pharmaceuticals, Neopharm, Inc., Proximatherapeutics, Guilford Pharmaceuticals, Grimshaw-Gudewicz Charitable Foundation, and others. Due to the generous support of these sponsors and other donors, the Symposium cost is only $65 for registrants, and additional family members can register for only $45 per person.

The Brain Tumor Society’s Annual Meeting and Dinner will follow the Symposium on the evening of Saturday, October 30. This will feature the presentation of the 2004 Research Grants, which are awarded to carefully selected basic scientific research projects. The Annual Meeting also recognizes important contributors to the Society’s mission with the presentation of the Roche Family Award.

Each year, more than 200,000 adults and children in the United States are diagnosed with a brain tumor. Brain tumors are the leading cause of solid tumor cancer death in and the second leading cause of cancer death in young adults ages 20 to 39.

BTS is committed to decreasing the paralyzing isolation experienced by so many patients through access to psychosocial support and creating connections for patients, survivors and their families with others affected by a brain tumor through our symposia and patient/family network. Through our comprehensive educational resources and publications, BTS seeks to arm patients and their caregivers with the knowledge they need to make more informed healthcare decisions. BTS also strives to improve early detection and maintains a national database of brain tumor treatment centers and support groups. BTS supports scientific and clinical conferences internationally to enable those specializing in various fields of brain tumors research and treatment an opportunity to share information and discoveries. The BTS Research Grant Program funds promising brain tumor research projects throughout the United States with the ultimate goal of finding a cure

For more information about Information is Power … Power is Hope or Brain Tumor Society, visit or call 1-800-770-TBTS (8287).


Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557